Provided by Tiger Trade Technology Pte. Ltd.

Puma Biotechnology

7.48
+0.24003.31%
Volume:164.86K
Turnover:1.22M
Market Cap:380.56M
PE:12.26
High:7.57
Open:7.41
Low:7.23
Close:7.24
52wk High:7.90
52wk Low:2.75
Shares:50.88M
Float Shares:38.56M
Volume Ratio:0.80
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6100
EPS(LYR):0.6100
ROE:27.97%
ROA:10.85%
PB:2.92
PE(LYR):12.26

Loading ...

Puma Biotechnology Added to Nasdaq Biotechnology Index

MT Newswires Live
·
Dec 23, 2025

Puma Biotechnology Joins Nasdaq Biotechnology Index

Reuters
·
Dec 23, 2025

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Dec 03, 2025

GoodRx Holdings And 2 Other Promising Penny Stocks

Simply Wall St.
·
Nov 27, 2025

Alpha Teknova Among 3 Penny Stocks Worth Noting

Simply Wall St.
·
Nov 26, 2025

Clover Health Investments And 2 Other Penny Stocks With Promising Financials

Simply Wall St.
·
Nov 25, 2025

November 2025's Top Penny Stocks To Watch

Simply Wall St.
·
Nov 24, 2025

Vanda Pharmaceuticals Leads 3 Promising Penny Stocks

Simply Wall St.
·
Nov 21, 2025

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Nov 20, 2025

Puma Biotechnology Q3 Adjusted EPS USD 0.21

Reuters
·
Nov 20, 2025

Puma Biotechnology Showcases Pipeline Progress and NERLYNX Commercial Updates in New Corporate Presentation

Reuters
·
Nov 18, 2025

Metalpha Technology Holding And 2 Other Promising Penny Stocks To Watch

Simply Wall St.
·
Nov 17, 2025

Director’s Bold Move: Major Stock Sale at Puma Biotechnology!

TIPRANKS
·
Nov 14, 2025

Director Michael Patrick Miller Sells Common Shares of Puma Biotechnology Inc

Reuters
·
Nov 14, 2025

BRIEF-Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Nov 08, 2025

3 Promising Penny Stocks With Market Caps Below $600M

Simply Wall St.
·
Nov 08, 2025

Cautious Hold Rating for Puma Biotechnology Amid Mixed Financial Signals and Future Uncertainties

TIPRANKS
·
Nov 07, 2025

Puma Biotechnology Q3 Adj. EPS $0.21 Beats $0.04 Estimate, Sales $54.500M Beat $51.000M Estimate

Benzinga
·
Nov 07, 2025

BRIEF-Puma Biotechnology Q3 Adjusted EPS USD 0.21

Reuters
·
Nov 07, 2025

Puma Biotechnology Outlook FY Revenue USD 220-223 Million

THOMSON REUTERS
·
Nov 07, 2025